Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Nuclear Science and Technology (3)
- Biological Systems (1)
- Biology and Environment (107)
- Biology and Soft Matter (1)
- Clean Energy (64)
- Climate and Environmental Systems (5)
- Computational Biology (2)
- Computational Engineering (2)
- Computer Science (2)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (3)
- Fusion Energy (1)
- Isotopes (7)
- Materials (24)
- Materials for Computing (3)
- Mathematics (1)
- National Security (8)
- Neutron Science (23)
- Supercomputing (71)
News Topics
- (-) Biomedical (2)
- (-) Environment (1)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (11)
- Bioenergy (1)
- Computer Science (2)
- Coronavirus (1)
- Cybersecurity (1)
- Decarbonization (1)
- Fusion (8)
- Isotopes (5)
- Materials Science (3)
- Molten Salt (4)
- Neutron Science (5)
- Nuclear Energy (36)
- Physics (2)
- Space Exploration (5)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
The Department of Energy’s Office of Science has selected three Oak Ridge National Laboratory scientists for Early Career Research Program awards.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.